🔎 Trials Near Me

Hjem › Metastatisk kreft › Florida › Orlando

Kliniske studier for Metastatisk kreft i Orlando, FL

29 studier for Metastatisk kreft søker deltakere på steder i og rundt Orlando (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07193511

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • Advent Health, Orlando
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • AdventHealth Cancer Institute, Orlando
Alder 19 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06586957

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

RekruttererFase 2/3
  • AdventHealth Orlando, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT06943755

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

RekruttererFase 1
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • og 4 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RekruttererFase 3
  • AdventHealth Orlando, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RekruttererFase 3
  • AdventHealth Orlando, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

RekruttererFase 3
  • AdventHealth Altamonte Springs, Altamonte Springs · 9 mi unna
  • Clermont Oncology Center, Clermont · 24 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

RekruttererFase 1/2
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • Orlando Health Orlando Regional Medical Center, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07227415

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Clinical Study Site, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Alder 18 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07038343

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RekruttererFase 3
  • Advent Health - Orlando, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06072612

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

RekruttererFase 1
  • Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT04913285

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

RekruttererFase 1
  • Adventhealth, Celebration · 17 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06803680

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

RekruttererFase 2
  • Orlando Health, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

RekruttererFase 1
  • Advent Health, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RekruttererFase 3
  • Research Site, Orlando
Alder 18 og eldre · Kvinner · Oppdatert 29. jul. 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • Orlando Health UF Health Cancer Center, Orlando
Alder 12 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT05533697

A Study of LY4175408 in Participants With Advanced Cancer

RekruttererFase 1
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07046923

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jun. 2026 · NCT05208047

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

RekruttererFase 1
  • Research Site, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06835569

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

RekruttererFase 3
  • AdventHealth Medical Group Oncology & Hematology at Orlando, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06064877

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

RekruttererFase 1/2
  • Florida Cancer Specialists, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 1. apr. 2026 · NCT05735080

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

RekruttererFase 1
  • AdventHealth Cancer Institute, Celebration · 17 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mar. 2026 · NCT05948865

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Florida Cancer Specialists-Lake Nona, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT07030257

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • Florida Cancer Specialists, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 16. des. 2025 · NCT06108050

Metastatisk kreft-studier i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.